Ligand validation:7WDI

IC6: (2S)-2-(6-imidazol-1-ylhexanoylamino)-3-phenyl-propanoic acid

IC6 is a Ligand Of Interest in 7WDI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7WDI_IC6_A_503	42%	29%	0.205	0.925	1.57	1.42	4	5	0	0	100%	0.6146
7WDI_IC6_B_503	41%	36%	0.199	0.914	1.49	1.11	3	2	1	0	100%	0.6146
7WDI_IC6_B_502	32%	41%	0.242	0.918	1.47	0.89	3	2	0	0	100%	0.5729
7WDI_IC6_A_502	30%	38%	0.247	0.91	1.51	0.98	3	2	0	0	100%	0.5729
7WDG_IC6_A_505	62%	39%	0.136	0.929	1.5	0.98	2	2	0	0	100%	0.6146
7Y0R_IC6_A_505	59%	9%	0.141	0.925	1.72	2.95	2	8	1	0	100%	0.6146
7WDH_IC6_A_503	59%	36%	0.133	0.914	1.51	1.08	3	3	0	0	100%	0.5729
7WDE_IC6_B_504	58%	41%	0.147	0.925	1.48	0.89	3	1	1	0	100%	0.6146
7WDD_IC6_B_503	56%	41%	0.142	0.915	1.49	0.88	3	-	0	0	100%	0.5729
7YJD_IC6_B_504	53%	30%	0.162	0.925	1.57	1.34	4	4	0	0	100%	0.6146

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.